AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $397,000 | -20.4% | 45,004 | -10.0% | 0.95% | -12.4% |
Q2 2018 | $499,000 | +4.6% | 50,004 | 0.0% | 1.08% | +15.6% |
Q1 2018 | $477,000 | +52.9% | 50,004 | +138.0% | 0.94% | +246.7% |
Q4 2017 | $312,000 | -24.5% | 21,009 | 0.0% | 0.27% | -27.2% |
Q3 2017 | $413,000 | +36.8% | 21,009 | 0.0% | 0.37% | +33.9% |
Q2 2017 | $302,000 | -22.0% | 21,009 | -50.0% | 0.28% | -3.5% |
Q1 2017 | $387,000 | – | 42,019 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |